Structure‐Based Design and ADME Screening of Benzimidazole Derivatives as Potential Therapeutics for Human Metapneumovirus (HMPV)
Macromolecular Symposia · 2026-02 · 415 (1)
DOI: 10.1002/masy.70159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Symposia, online erschienen am 13.10.2025. Verfasst von Nuaman F. Alheety und 4 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Human metapneumovirus (HMPV) remains a significant challenge in respiratory healthcare, primarily due to the lack of targeted antiviral therapies and vaccines. In this study, six new benzimidazole derivatives ( M1–M6 ) were synthesized and characterized using FT–IR and 1 H‐NMR techniques. These compounds showed potential activity against the RNA‐dependent RNA polymerase enzyme of HMPV. To evaluate benzimidazole and its six derivatives as potential polymerase inhibitors, in silico molecular docking studies were performed. The results indicated that the effectiveness of compounds ( M1–M6 ) is comparable to MRK‐1 , a synthetic non‐nucleoside inhibitor of the polymerase that blocks conformational changes necessary for the enzyme to initiate RNA synthesis and transition into the elongation phase. Among the tested compounds, M1 , M4 , and M5 demonstrated the most favorable binding energies with the protein 8FPJ (−5.270, −5.406, and −5.622 kcal/mol, respectively), whereas MRK‐1 showed a binding energy of −8.471 kcal/mol. Compounds M2 , M3 , and M6 also exhibited good binding affinities (−6.477, −6.819, and −6.480 kcal/mol, respectively). Pharmacokinetic and toxicity analyses further supported the potential candidacy of these compounds as antiviral agents targeting the RNA‐dependent RNA polymerase enzyme.
Zitieren
APA
Alheety, N. F., Al‐Kubaisi, A. A., Mukhlif, M. Y., Alheety, M. A., & Besbes, R. (2026). Structure‐Based Design and ADME Screening of Benzimidazole Derivatives as Potential Therapeutics for Human Metapneumovirus (HMPV). Macromolecular Symposia, 415(1). https://doi.org/10.1002/masy.70159
Vancouver
Alheety NF, Al‐Kubaisi AA, Mukhlif MY, Alheety MA, Besbes R. Structure‐Based Design and ADME Screening of Benzimidazole Derivatives as Potential Therapeutics for Human Metapneumovirus (HMPV). Macromolecular Symposia. 2026;415(1). doi:10.1002/masy.70159
BibTeX
@article{Alheety2026,
author = {Alheety, Nuaman F. and Al‐Kubaisi, Ahmed A. and Mukhlif, Mahmood Yaseen and Alheety, Mustafa A. and Besbes, Rafâa},
title = {Structure‐Based Design and ADME Screening of Benzimidazole Derivatives as Potential Therapeutics for Human Metapneumovirus (HMPV)},
journal = {Macromolecular Symposia},
year = {2026},
volume = {415},
number = {1},
doi = {10.1002/masy.70159}
}
EUVIMED